Literature DB >> 15963405

Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.

Brian Olshansky1, Eliot N Heller, L Brent Mitchell, Mary Chandler, William Slater, Martin Green, Michael Brodsky, Patrick Barrell, H Leon Greene.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the associations of transthoracic echocardiographic parameters with recurrent atrial fibrillation (AF) and/or stroke.
BACKGROUND: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study, an evaluation of elderly patients with AF at risk for stroke, provided an opportunity to evaluate the implications of echocardiographic parameters in patients with AF.
METHODS: Transthoracic echocardiographic measures of mitral regurgitation (MR), left atrial (LA) diameter, and left ventricular (LV) function were evaluated in the AFFIRM rate- and rhythm-control patients who had sinus rhythm resume and had these data available. Risk for recurrent AF or stroke was evaluated with respect to transthoracic echocardiographic measures.
RESULTS: Of 2,474 patients studied, 457 had > or =2(+)/4(+) MR, and 726 had a LA diameter >4.5 cm. The LV ejection fraction was abnormal in 543 patients. The cumulative probabilities of at least one AF recurrence/stroke were 46%/1% after 1 year and 84%/5% by the end of the trial (> 5 years), respectively. Multivariate analysis showed that randomization to the rhythm-control arm (hazard ratio [HR] = 0.64; p < 0.0001) and a qualifying episode of AF being the first known episode (HR = 0.70; p < 0.0001) were associated with decreased risk. Duration of qualifying AF episode >48 h (HR = 1.55; p < 0.0001) and LA diameter (p = 0.008) were associated with an increased risk of recurrent AF. Recurrent AF was more likely with larger LA diameters (HR = 1.21, 1.16, and 1.32 for mild, moderate, and severe enlargement, respectively). No transthoracic echocardiographic measures were associated with risk of stroke.
CONCLUSIONS: In the AFFIRM study, large transthoracic echocardiographic LA diameters were associated with recurrent AF, but no measured echocardiographic parameter was associated with stroke.

Entities:  

Mesh:

Year:  2005        PMID: 15963405     DOI: 10.1016/j.jacc.2005.03.020

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  41 in total

1.  Association between left atrial size and measures of adiposity among normal adolescent boys.

Authors:  Valeria Hirschler; H Laura Perez Acebo; Graciela B Fernandez; Sandra Ferradas; Karin Oestreicher
Journal:  Pediatr Cardiol       Date:  2011-09-28       Impact factor: 1.655

2.  The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy.

Authors:  Deepak K Gupta; Robert P Giugliano; Christian T Ruff; Brian Claggett; Sabina Murphy; Elliott Antman; Michele F Mercuri; Eugene Braunwald; Scott D Solomon
Journal:  J Am Soc Echocardiogr       Date:  2016-04-20       Impact factor: 5.251

Review 3.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

4.  Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation.

Authors:  Teresa Strisciuglio; Giuseppe Di Gioia; Sofia Chatzikyriakou; Etel Silva Garcia; Emanuele Barbato; Peter Geelen; Tom De Potter
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-16       Impact factor: 2.357

5.  Rate versus rhythm control strategies for AF.

Authors:  Brian Olshansky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

Review 6.  Atrial Remodelling : Role in Atrial Fibrillation Ablation.

Authors:  Herko Grubitzsch; Wilhelm Haverkamp
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 7.  The Role of Atrial Structural Remodeling in Atrial Fibrillation Ablation:An Imaging Point of View for Predicting Recurrence.

Authors:  Yasushi Akutsu; Kaoru Tanno; Youichi Kobayashi
Journal:  J Atr Fibrillation       Date:  2012-08-20

Review 8.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

9.  Echocardiographic features of patients with paroxysmal atrial fibrillation.

Authors:  Yucel Colkesen; Tayfun Acil; Senol Demircan; Alpay T Sezgin; Bulent Ozin; Haldun Muderrisoglu
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-28       Impact factor: 2.357

10.  Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system.

Authors:  Suman S Kuppahally; Elyse Foster; Stanford Shoor; Anthony E Steimle
Journal:  Int Arch Med       Date:  2009-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.